Case Study: Leading U.S. Pharmaceutical Company improves portfolio decisions with SmartOrg

a leading u.s. pharmaceutical company uses SmartOrg to manage 5,000-to-1 drug development odds

A leading U.S. pharmaceutical company faced the challenge of prioritizing its extensive R&D projects in a high-risk industry where only a small fraction of drug candidates succeed. To focus its resources on the most promising opportunities and eliminate less optimal projects, the company turned to SmartOrg for its strategic portfolio management software and expertise.

SmartOrg implemented its portfolio management technology platform to provide a disciplined, data-driven approach for evaluating projects. The solution enabled the company's leadership to make faster, more informed decisions by clearly visualizing information and balancing risk versus return. As a result, the client could quickly identify and stop losing projects early, allowing them to reallocate resources to therapies with the highest chance of success and ultimately drive greater value for stakeholders.